Fetal programming: <i>in utero</i> exposure to acrylamide leads to intergenerational disrupted ovarian function and accelerated ovarian aging

Nouf Aldawood; Maroua Jalouli; Abdulkarem Alrezaki; Saber Nahdi; Abdullah Alamri; Mohamed Alanazi; Salim Manoharadas; Saleh Alwasel; Abdel Halim Harrath

doi:doi:10.18632/aging.204269

← Back

Research Paper Volume 14, Issue 17 pp 6887—6904

Fetal programming: in utero exposure to acrylamide leads to intergenerational disrupted ovarian function and accelerated ovarian aging

Figure 1. (A) The ovary weight in AF1 groups compared to that in the control group CF1 recorded a significant elevation with all doses of ACR (2.5, 10, and 20 mg/kg/day). (B) The ovary weight in AF2 groups recorded a significant decrease in ovary weight with all doses compared to that in the control group CF2.